Cell and Gene Outsourcing

  1. What Recent FDA CRLs Reveal About CMC 8/14/2026

    FDA-released CRLs reveal common reasons drug applications miss approval. Many point to recurring CMC issues that can be identified and addressed earlier in development.

  2. What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is? 8/13/2026

    Rethink vendor evaluation by looking beyond indication experience to discover how cross-trial adaptability, proactive risk management, and team judgment drive true clinical trial resilience.

  3. The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast 8/13/2026

    Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.

  4. No-Frills, High-Impact Vendor Oversight: 4 Principles That Never Let Me Down 8/13/2026

    Discover a streamlined four-pillar framework for vendor oversight. Learn how tracking essential KPIs across time, budget, quality, and relationships drives accountability in clinical operations.

  5. Killing Excel: The Quiet Crisis In Clinical Trials 8/13/2026

    Stop relying on spreadsheets for critical clinical trial decisions. Learn how standardizing vendor selection eliminates inefficiencies and protects budgets.

  6. Keep Your Vendors On Track: The 4 KPIs That Matter Most 8/13/2026

    Master clinical vendor management with four key pillars: time, money, quality, and relationships. Learn which essential KPIs keep your trial timelines and budgets on track.

  7. Cagey Sponsors, Defensive Vendors: Observations On How Transparency Breaks Down 8/13/2026

    Discover how hidden operational uncertainties trigger defensive pricing and scope disputes—and how early transparency builds stable, high-performing research partnerships.

  8. A System For Better Vendor Relationships 8/13/2026

    Shift your clinical trial strategy with zero-cost habits that build trust, protect trial continuity, and transform routine supplier management into resilient, high-performing partnerships.

  9. When Early CRO Wins Quietly Create Long-Term Study Risk 8/13/2026

    Discover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.

  10. The Future Of DNA Production: Speed, Scalability, And Cell-free Innovation 8/13/2026

    Replace traditional plasmid manufacturing with cell-free enzymatic production for scalable, cost-efficient development free of bacterial backbone sequences.